TITLE

Radical prostatectomy reduced death and progression more than watchful waiting in early prostate cancer: COMMENTARY

AUTHOR(S)
Munro, Alastair J.
PUB. DATE
November 2005
SOURCE
ACP Journal Club;Nov/Dec2005, Vol. 143 Issue 3, p57
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article comments on a study which found that radical prostatectomy reduced death and progression more than watchful waiting in early prostate cancer. The study claims that RP is better than WW for early-stage prostate cancer, a conclusion that is largely based on improved survival in patients less than 65 years of age treated with RP. The study was designed nearly 20 years ago, and in the meantime, ad hoc screening and stage migration have changed the clinical picture of early prostate cancer. The study did not include radiotherapy, either external beam or brachytherapy. Patients who are actively monitored may have a higher risk for symptoms related to disease recurrence or progression, plus any anxieties associated with having untreated cancer.
ACCESSION #
18925722

 

Related Articles

  • New Weapons Against Prostate Cancer. Saltus, Richard // Popular Science;Aug2000, Vol. 257 Issue 2, p58 

    Provides information on several treatments for prostate cancer. Radical prostatectomy; External-beam therapy; Brachytherapy; X-ray treatment. INSETS: Catching Cancer Early;Hope from Herbs.

  • Use of brachytherapy for localized prostate cancer has declined. Todak, Alexandra // Hem/Onc Today;6/10/2014, Vol. 15 Issue 11, p7 

    The article reports on the downturn in the use of brachytherapy as treatment for men with lower-risk prostate cancer based on information from National Cancer Data Base institutions and mentions topics including rise in utilization of radical prostatectomy and active surveillance.

  • Three modalities show equal outcomes in localized PCa. Guttman, Cheryl // Urology Times;Jun2004, Vol. 32 Issue 8, p1 

    Reports that three modalities show equal outcomes in localized prostate cancer. Monotherapy with radical prostatectomy; External beam radiation therapy; Permanent prostate brachytherapy.

  • In low-risk PCa, QoL is key to treatment choice. Sleve, Vonne // Urology Times;8/1/2008, Vol. 36 Issue 9, p10 

    The article discusses the significance of active surveillance, interstitial prostate brachytherapy, and external beam radiotherapy in treating patients with low-risk localized prostate cancer. The technique's focus is to treat side effects and their impact on quality of life. In a study, men who...

  • Prostate cancer. Anderson, Paul // GP: General Practitioner;3/23/2007, p31 

    The article presents information on prostate cancer including its treatment, testing and screening tool. Prostate cancer is the only human cancer that although curable, and often does not need to be cured. Radical prostatectomy, radical radiotherapy and brachytherapy can be used for the...

  • PCa radiotherapy raises bladder, rectal Ca risk. Tennant, Scott // Urology Times;9/1/2008, Vol. 36 Issue 11, p21 

    The article reports on the study which reveals that men who receive radiotherapy for treatment of localized prostate cancer have an elevated risk of developing bladder and rectal cancer. The study showed that the relative risk of developing bladder cancer was 1.88 after external beam radiation...

  • New technologies for prostate cancer therapy make debut. Haimovitch, Larry // Medical Device Daily;5/22/2008, Vol. 12 Issue 99, p1 

    The article reports on new technologies that will help diagnose and treat prostate cancer. These technologies were presented during the American Urological Association (AUA) meeting in Orlando, Florida. These new technologies include the robotic radical prostatectomy (RP), marketed by Intuitive...

  • Commentary. Munro, Alastair J. // Evidence Based Medicine;Dec2005, Vol. 10 Issue 6, p168 

    The article comments on a study which compares radical prostatectomy and watchful waiting in the treatment of postate cancer patients. The study claims that RP is better than WW, a conclusion that is based on improved survival in patients below sixty-five years of age. It would seem that RP is...

  • Brachytherapy may not be indicated in higher-risk PCa patients. Guttman, Cheryl // Urology Times;Nov98, Vol. 26 Issue 11, p3 

    Details findings of a retrospective cohort study from the University of Pennsylvania which cautions urologists about overapplying interstitial seed implantation or brachytherapy as a definitive treatment for localized prostate cancer. Use of multivariable analytic techniques to compare...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics